FDA Rush To Meet Pediatric Statutory Deadline Compromised Policy - Lawsuit
This article was originally published in The Tan Sheet
Executive Summary
FDA's push to meet statutory deadlines set for the FDA Modernization Act pediatric exclusivity provision short-changed public input and resulted in too broad a drug list for which innovator companies may gain exclusivity, generic groups assert in a lawsuit filed in D.C. federal court Feb. 19.